PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Alex Rajewski

Tethers Unlimited (United States)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patients

Cancer Research Communications

Single-centre feasibility study of organoid drug testing in a small sample with uncontrolled clinical outcomes; demonstrates proof-of-concept but lacks comparison group and prospective validation.

PreliminaryAlex Rajewski Cholangiocarcinoma and Gallbladder Cancer Studies Payel Chatterjee

Reported

Organoid derivation rate26/43

Proportion with drug sensitivity24/26 (92.3%)

Average number of drugs tested pe…50

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support